Skip to Content

Elo Life Systems Secures $20.5 Million to Revolutionize Ingredient Production with Molecular Farming

Advancing Food Technology Through Innovative Funding

Elo Life Systems, based in Durham, NC, has successfully raised $20.5 million in a Series A2 funding round, surpassing initial expectations. This investment was led by prominent firms DCVC Bio and Novo Holdings, supplemented by contributions from Hanwha Next Generation Opportunity Fund, AccelR8, and Alexandria Venture Investments. With this latest injection, Elo Life Systems has now accumulated $45 million to further its innovative endeavors in the food and beverage industry.

Pioneering Molecular Farming for Sustainable Solutions

Elo Life Systems stands out by employing a molecular farming platform, which enables the cultivation of high-value ingredients that are difficult to extract naturally and cannot be synthesized traditionally. This strategic approach positions crops as biofactories, aiming to solve significant challenges in ingredient production. The new funding will fuel the expansion of Elo’s molecular farming operations, enhancing the development of sustainable and nutritious ingredients, and improving crop protection and productivity.

Shaping the Future of Food with Groundbreaking Products

CEO Todd Rands articulated Elo’s dedication to harnessing natural processes to improve food taste, health benefits, and environmental impact. The company is set to launch its first product, a monk fruit-based sweetener, in 2026, aimed at reducing dependency on sugar and artificial sweeteners. Elo is also advancing the development of other innovative products, including novel proteins, natural preservatives, and premium flavors, promising a transformative impact on the food and beverage sector.